Defining T-Cell Responses to Mutant and Non-Mutant Antigens in Mouse Melanoma During Anti-CTLA-4 Immune Checkpoint Therapy

Authors

Amangelin Diore Jalbuena MS, The University of Texas MD Anderson Cancer CenterFollow
Sunita Keshari PhD, The University of Texas MD Anderson Cancer Center
Matthew Gubin PhD, The University of Texas MD Anderson Cancer Center

Files

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston

Keywords

neoantigens, immune checkpoint therapy, mLama4, mAlg8, therapeutic cancer vaccine

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Program Affiliation

CPRTP Summer Research Experience

Recommended Citation

Jalbuena, Amangelin Diore MS; Keshari, Sunita PhD; and Gubin, Matthew PhD, "Defining T-Cell Responses to Mutant and Non-Mutant Antigens in Mouse Melanoma During Anti-CTLA-4 Immune Checkpoint Therapy" (2021). Summer Experience 2021. 210.
https://openworks.mdanderson.org/sumexp21/210